Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 456.22M
June 30, 2026 1.391M
March 31, 2026 2.823M
December 31, 2025 3.24M
September 30, 2025 4.568M
June 30, 2025 3.006M
March 31, 2025 3.639M
December 31, 2024 3.232M
September 30, 2024 2.872M
June 30, 2024 4.588M
March 31, 2024 5.696M
December 31, 2023 7.571M
September 30, 2023 9.108M
June 30, 2023 5.641M
March 31, 2023 7.169M
December 31, 2022 13.38M
September 30, 2022 20.40M
June 30, 2022 30.32M
Date Value
March 31, 2022 41.12M
December 31, 2021 53.96M
September 30, 2021 62.50M
June 30, 2021 70.39M
March 31, 2021 41.43M
December 31, 2020 54.40M
September 30, 2020 66.84M
June 30, 2020 56.46M
March 31, 2020 67.10M
December 31, 2019 97.60M
September 30, 2019 117.03M
June 30, 2019 141.03M
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018
December 31, 2017 0.00

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Q32 Bio, Inc. 289.59M
IRulya Therapeutics, Inc. 115.98M
Climb Bio, Inc. 205.42M
PepGen Inc. 117.24M
Bridgebio Oncology Therapeutics, Inc. 225.71M